首页 > 最新文献

Neurologia Argentina最新文献

英文 中文
Poliomielitis y síndrome pospoliomielítico en Argentina 阿根廷的脊髓灰质炎和脊髓灰质炎后综合征
Q4 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.neuarg.2024.04.002

Introduction

The development of new symptoms of weakness, pain and fatigue decades after having experienced poliomyelitis is known as post-polio syndrome (PPS). In Argentina, there is no data available on its prevalence.

Objectives

To determine the impact and sequelae of polio survivors in Argentina. To identify and characterize patients with PPS.

Methods

A descriptive cross-sectional study that included 698 patients from different provinces of Argentina with a history of poliomyelitis, between 2019 and 2022. Online and telephone surveys were conducted regarding socioeconomic variables, age of polio diagnosis, PPS symptoms, diagnostic studies, and treatment.

Results

Most patients experienced polio between 1 and 3 years of age (mean 1.48). PPS was observed in 61,8% of the patients. Common PPS symptoms reported were increased weakness (89%), muscle pain (77%), sleep disorders (76%), and fatigue (8%). The average age of symptom onset was 50 years. Most patients reported difficulties in receiving a proper diagnosis and treatment. The diagnosis of PPS was significantly more frequent in women (60,04%) compared to men (39,95%) (p = 0.000).

Conclusions

61,8% of polio survivors in Argentina have PPS. Recognizing PPS and its prevalence will help in planning public policies aimed at proper diagnosis and treatment.

导言:脊髓灰质炎患者在经历数十年的脊髓灰质炎后出现新的虚弱、疼痛和疲劳症状,被称为脊髓灰质炎后综合征(PPS)。目标 确定阿根廷脊髓灰质炎幸存者的影响和后遗症。方法在 2019 年至 2022 年期间,对来自阿根廷不同省份、有脊髓灰质炎病史的 698 名患者进行横断面描述性研究。就社会经济变量、小儿麻痹症诊断年龄、PPS 症状、诊断研究和治疗进行了在线和电话调查。61.8%的患者出现 PPS。常见的 PPS 症状包括乏力加重(89%)、肌肉疼痛(77%)、睡眠障碍(76%)和疲劳(8%)。发病的平均年龄为 50 岁。大多数患者表示很难得到正确的诊断和治疗。与男性(39.95%)相比,女性(60.04%)的 PPS 诊断率明显更高(P = 0.000)。认识到 PPS 及其发病率将有助于制定旨在正确诊断和治疗的公共政策。
{"title":"Poliomielitis y síndrome pospoliomielítico en Argentina","authors":"","doi":"10.1016/j.neuarg.2024.04.002","DOIUrl":"10.1016/j.neuarg.2024.04.002","url":null,"abstract":"<div><h3>Introduction</h3><p>The development of new symptoms of weakness, pain and fatigue decades after having experienced poliomyelitis is known as post-polio syndrome (PPS). In Argentina, there is no data available on its prevalence.</p></div><div><h3>Objectives</h3><p>To determine the impact and sequelae of polio survivors in Argentina. To identify and characterize patients with PPS.</p></div><div><h3>Methods</h3><p>A descriptive cross-sectional study that included 698 patients from different provinces of Argentina with a history of poliomyelitis, between 2019 and 2022. Online and telephone surveys were conducted regarding socioeconomic variables, age of polio diagnosis, PPS symptoms, diagnostic studies, and treatment.</p></div><div><h3>Results</h3><p>Most patients experienced polio between 1 and 3 years of age (mean 1.48). PPS was observed in 61,8% of the patients. Common PPS symptoms reported were increased weakness (89%), muscle pain (77%), sleep disorders (76%), and fatigue (8%). The average age of symptom onset was 50 years. Most patients reported difficulties in receiving a proper diagnosis and treatment. The diagnosis of PPS was significantly more frequent in women (60,04%) compared to men (39,95%) (p<!--> <!-->=<!--> <!-->0.000).</p></div><div><h3>Conclusions</h3><p>61,8% of polio survivors in Argentina have PPS. Recognizing PPS and its prevalence will help in planning public policies aimed at proper diagnosis and treatment.</p></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"16 3","pages":"Pages 113-121"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141032193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NeuroGPT, evaluando ChatGPT: Diagnóstico y tratamiento de 72 pacientes neurológicos NeuroGPT, 评估 ChatGPT:72 名神经病患者的诊断和治疗
Q4 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.neuarg.2024.08.002
Alejandro Fernández Cabrera , Jesús García de Soto , Paula Santamaría Montero , Héctor Chinea García , Robustiano Pego Reigosa

Introduction

There has been a significant boom in the field of artificial intelligence in recent years, especially in terms of accessibility and its use in different areas. This study attempts to determine if an AI can diagnose neurology patients.

Objective

To evaluate the utility and accuracy of ChatGPT 3.5 as a tool for conducting patient history, diagnosis, and treatment in cases of neurological pathology.

Materials and methods

A descriptive qualitative observational study was conducted, without intervention in patients, focused on evaluating the utility and accuracy of ChatGPT 3.5 for taking patient history, diagnosis, and treatment in patients with neurological pathology. The information provided to the neurologist was entered into the language model. Subsequently, the questions determined by ChatGPT were asked, and the complete neurological examination was provided. ChatGPT's diagnosis was compared with that of two different neurologists. Recruitment took place from May 2022 to June 2023 in a neurology consultation at a medium-sized hospital in Spain.

Results

A total of 72 patients (median age 58.71 years and 55.6% female) were enrolled in this study. Complementary tests suggested by the AI were considered correct in 33.3% of cases. The accuracy of the AI's diagnosis was 44.4%, and treatment recommendations were correct in 37.5%. The diagnosis was checked by two different neurologists following the latest national and international Neurology guidelines. In most cases, the diagnosis between the two neurologists agreed, with a kappa coefficient of 0.94.

Conclusions

Although we are in an unprecedented era of advancement in the field of artificial intelligence, it does not seem that ChatGPT can currently replace the evaluation of a neurology specialist.

导言近年来,人工智能领域蓬勃发展,尤其是在可访问性及其在不同领域的应用方面。本研究试图确定人工智能是否能诊断神经病学患者。目的评估 ChatGPT 3.5 作为神经病学病例的病史采集、诊断和治疗工具的实用性和准确性。材料和方法在不对患者进行干预的情况下,进行了一项描述性定性观察研究,重点评估 ChatGPT 3.5 在神经病学病例的病史采集、诊断和治疗方面的实用性和准确性。向神经科医生提供的信息被输入到语言模型中。随后,询问 ChatGPT 确定的问题,并提供完整的神经系统检查。ChatGPT 的诊断结果与两位不同神经科医生的诊断结果进行了比较。本研究于 2022 年 5 月至 2023 年 6 月在西班牙一家中型医院的神经科会诊中招募了 72 名患者(中位年龄 58.71 岁,55.6% 为女性)。33.3%的病例认为人工智能建议的辅助检查是正确的。人工智能诊断的准确率为 44.4%,治疗建议的正确率为 37.5%。诊断由两名不同的神经病学专家根据最新的国内和国际神经病学指南进行核对。在大多数情况下,两位神经科医生的诊断结果一致,卡帕系数为 0.94。结论虽然我们正处于人工智能领域前所未有的进步时代,但目前看来 ChatGPT 还不能取代神经科专家的评估。
{"title":"NeuroGPT, evaluando ChatGPT: Diagnóstico y tratamiento de 72 pacientes neurológicos","authors":"Alejandro Fernández Cabrera ,&nbsp;Jesús García de Soto ,&nbsp;Paula Santamaría Montero ,&nbsp;Héctor Chinea García ,&nbsp;Robustiano Pego Reigosa","doi":"10.1016/j.neuarg.2024.08.002","DOIUrl":"10.1016/j.neuarg.2024.08.002","url":null,"abstract":"<div><h3>Introduction</h3><p>There has been a significant boom in the field of artificial intelligence in recent years, especially in terms of accessibility and its use in different areas. This study attempts to determine if an AI can diagnose neurology patients.</p></div><div><h3>Objective</h3><p>To evaluate the utility and accuracy of ChatGPT 3.5 as a tool for conducting patient history, diagnosis, and treatment in cases of neurological pathology.</p></div><div><h3>Materials and methods</h3><p>A descriptive qualitative observational study was conducted, without intervention in patients, focused on evaluating the utility and accuracy of ChatGPT 3.5 for taking patient history, diagnosis, and treatment in patients with neurological pathology. The information provided to the neurologist was entered into the language model. Subsequently, the questions determined by ChatGPT were asked, and the complete neurological examination was provided. ChatGPT's diagnosis was compared with that of two different neurologists. Recruitment took place from May 2022 to June 2023 in a neurology consultation at a medium-sized hospital in Spain.</p></div><div><h3>Results</h3><p>A total of 72 patients (median age 58.71 years and 55.6% female) were enrolled in this study. Complementary tests suggested by the AI were considered correct in 33.3% of cases. The accuracy of the AI's diagnosis was 44.4%, and treatment recommendations were correct in 37.5%. The diagnosis was checked by two different neurologists following the latest national and international Neurology guidelines. In most cases, the diagnosis between the two neurologists agreed, with a kappa coefficient of 0.94.</p></div><div><h3>Conclusions</h3><p>Although we are in an unprecedented era of advancement in the field of artificial intelligence, it does not seem that ChatGPT can currently replace the evaluation of a neurology specialist.</p></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"16 3","pages":"Pages 136-141"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demencias. ¿Qué hacemos hoy y qué podríamos hacer? Análisis de una cohorte en el mundo real de pacientes con trastornos cognitivos y conductuales 痴呆症:我们今天在做什么,我们还能做什么?对现实世界中认知和行为障碍患者群组的分析。
Q4 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.neuarg.2024.08.005
Daniel Raul Zuin Dr., Francisco Peñalver Dr., María Paula Zuin Lic.

Introduction and objectives

Dementia (D) are presented with high prevalence in older adults with great personal and socioeconomic impact. The objective of this study was to determine in patients, from the real world, who consulted for cognitive behavioral disorders (CBD), the diagnostic conditions and the therapeutic measures before and after the evaluation.

Material and method

Naturalistic horizontal study that included patients who made their first consultation for CBD in a reference center in Mendoza, Argentina.

Results

A total of 135 patients were included, mean age 76 years. A definite CBD was diagnosed in 124 patients (92%). The 48% corresponded to Alzheimer's (AD), 23% Mild Neurocognitive Disorder, 12% D. Mixed, 8% D. Lewy (DL), 3% D. Frontotemporal (DFT) and 6% other impairments. 115 patients had one or more previous consultations for CBB (ULT), the rest did so for the first time (PV). In the ULT group, 74% were evaluated by primary care physicians (general or family). The presence of D/TCM is related to older age (76/69 years P=.009) and duration of symptoms (2.6/1.4 years P=.014). 29% of ULT patients had undergone routine laboratory and 56% neuroimaging. Vitamin B12 (D-B12) deficiency was detected in 21%. Regarding the previous diagnosis: 48% did not have a definite diagnosis, 26% reported diagnoses such as senility, Senile D, atherosclerosis, age-related D, etc. In the group of treatable D. 37% did not receive any type of medication, 16% received medications without any degree of recommendation for use, 40% were taking memantine (20% optimal doses), 23% an anticholinesterases drugs (10% optimal doses), 15% were on combination therapy and of them only 5% in effective doses. 20% of the total group had been indicated, mentioned and/or performed regular physical activity, 17% cognitive stimulation and 14% healthy diet.

Conclusions

It is imperative to implement energetic and sustained educational measures to disseminate diagnostic and therapeutic algorithms for the correct management of CBD. These should include the use of non-pharmacological therapies, also around prevention. This will optimize and homogenize the comprehensive management of these devastating diseases.

导言和目标痴呆症(D)在老年人中的发病率很高,对个人和社会经济产生了重大影响。本研究旨在确定现实世界中因认知行为障碍(CBD)就诊的患者、诊断条件以及评估前后的治疗措施。124名患者(92%)被确诊为CBD。48%的患者患有阿尔茨海默氏症(AD),23%患有轻度神经认知障碍,12%患有混合型阿尔茨海默氏症,8%患有路易型阿尔茨海默氏症(DL),3%患有前颞叶阿尔茨海默氏症(DFT),6%患有其他障碍。115 名患者曾接受过一次或多次 CBB 咨询(ULT),其余患者则是首次接受 CBB 咨询(PV)。在 ULT 组中,74% 的患者由初级保健医生(全科或家庭医生)进行评估。D/TCM 的存在与年龄(76/69 岁,P=.009)和症状持续时间(2.6/1.4 年,P=.014)有关。29%的 ULT 患者接受过常规实验室检查,56%的患者接受过神经影像学检查。21%的患者被检测出缺乏维生素B12(D-B12)。关于既往诊断:48%的人没有明确诊断,26%的人报告的诊断包括老年性痴呆、老年性D、动脉粥样硬化、与年龄有关的D等。在可治疗的 D 组中,37% 的人没有接受过任何类型的药物治疗,16% 的人接受过没有任何推荐使用程度的药物治疗,40% 的人在服用美金刚(20% 最佳剂量),23% 的人在服用抗胆碱酯酶药物(10% 最佳剂量),15% 的人在接受综合治疗,其中只有 5%的人在服用有效剂量的药物。20%的患者表示、提到和/或进行了定期体育锻炼,17%的患者进行了认知刺激,14%的患者进行了健康饮食。这些措施应包括非药物疗法的使用,以及预防措施。这将优化和统一这些破坏性疾病的综合管理。
{"title":"Demencias. ¿Qué hacemos hoy y qué podríamos hacer? Análisis de una cohorte en el mundo real de pacientes con trastornos cognitivos y conductuales","authors":"Daniel Raul Zuin Dr.,&nbsp;Francisco Peñalver Dr.,&nbsp;María Paula Zuin Lic.","doi":"10.1016/j.neuarg.2024.08.005","DOIUrl":"10.1016/j.neuarg.2024.08.005","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>Dementia (D) are presented with high prevalence in older adults with great personal and socioeconomic impact. The objective of this study was to determine in patients, from the real world, who consulted for cognitive behavioral disorders (CBD), the diagnostic conditions and the therapeutic measures before and after the evaluation.</p></div><div><h3>Material and method</h3><p>Naturalistic horizontal study that included patients who made their first consultation for CBD in a reference center in Mendoza, Argentina.</p></div><div><h3>Results</h3><p>A total of 135 patients were included, mean age 76 years. A definite CBD was diagnosed in 124 patients (92%). The 48% corresponded to Alzheimer's (AD), 23% Mild Neurocognitive Disorder, 12% D. Mixed, 8% D. Lewy (DL), 3% D. Frontotemporal (DFT) and 6% other impairments. 115 patients had one or more previous consultations for CBB (ULT), the rest did so for the first time (PV). In the ULT group, 74% were evaluated by primary care physicians (general or family). The presence of D/TCM is related to older age (76/69 years <em>P</em>=.009) and duration of symptoms (2.6/1.4 years <em>P</em>=.014). 29% of ULT patients had undergone routine laboratory and 56% neuroimaging. Vitamin B<sub>12</sub> (D-B<sub>12</sub>) deficiency was detected in 21%. Regarding the previous diagnosis: 48% did not have a definite diagnosis, 26% reported diagnoses such as senility, Senile D, atherosclerosis, age-related D, etc. In the group of treatable D. 37% did not receive any type of medication, 16% received medications without any degree of recommendation for use, 40% were taking memantine (20% optimal doses), 23% an anticholinesterases drugs (10% optimal doses), 15% were on combination therapy and of them only 5% in effective doses. 20% of the total group had been indicated, mentioned and/or performed regular physical activity, 17% cognitive stimulation and 14% healthy diet.</p></div><div><h3>Conclusions</h3><p>It is imperative to implement energetic and sustained educational measures to disseminate diagnostic and therapeutic algorithms for the correct management of CBD. These should include the use of non-pharmacological therapies, also around prevention. This will optimize and homogenize the comprehensive management of these devastating diseases.</p></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"16 3","pages":"Pages 142-152"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telemedicina: un facilitador para el acceso a programas de actividad física para pacientes con esclerosis múltiple en Colombia 远程医疗:哥伦比亚多发性硬化症患者参加体育活动计划的促进因素
Q4 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.neuarg.2024.04.004

Multiple sclerosis is an autoimmune disease that damages the central nervous system, causing neurological impairment. Its impact on quality of life and medical costs is significant. Providing pharmacological treatment and promoting physical activity are essential to enhance well-being. However, in Colombia, barriers such as social inequalities and limited access to healthcare facilities hinder this. Implementing physical activity and rehabilitation programs via telemedicine could overcome these barriers and benefit patients. Addressing this need is crucial to improve the health of those suffering from multiple sclerosis in Colombia.

多发性硬化症是一种自身免疫性疾病,会损害中枢神经系统,造成神经功能损伤。它对生活质量和医疗费用的影响非常大。提供药物治疗和促进体育锻炼对提高生活质量至关重要。然而,在哥伦比亚,社会不平等和医疗设施有限等障碍阻碍了这一目标的实现。通过远程医疗实施体育锻炼和康复计划可以克服这些障碍,使患者受益。满足这一需求对于改善哥伦比亚多发性硬化症患者的健康状况至关重要。
{"title":"Telemedicina: un facilitador para el acceso a programas de actividad física para pacientes con esclerosis múltiple en Colombia","authors":"","doi":"10.1016/j.neuarg.2024.04.004","DOIUrl":"10.1016/j.neuarg.2024.04.004","url":null,"abstract":"<div><p>Multiple sclerosis is an autoimmune disease that damages the central nervous system, causing neurological impairment. Its impact on quality of life and medical costs is significant. Providing pharmacological treatment and promoting physical activity are essential to enhance well-being. However, in Colombia, barriers such as social inequalities and limited access to healthcare facilities hinder this. Implementing physical activity and rehabilitation programs via telemedicine could overcome these barriers and benefit patients. Addressing this need is crucial to improve the health of those suffering from multiple sclerosis in Colombia.</p></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"16 3","pages":"Pages 153-158"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141394343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enfermedad de Parkinson y tabaquismo: una revisión sistemática 帕金森病与吸烟:系统综述
Q4 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.neuarg.2024.05.001
Ledmar Jovanny Vargas Rodriguez , Jamir Muñoz-Torres , Duvier Fabián Meza , José Mario Vásquez , Oriana Saavedra Salinas

Introduction

Parkinson's disease is a neurodegenerative process of onset in adulthood, characterized by signs such as bradykinesia, resting tremor, rigidity, increased muscle tension, resistance to movement and postural instability with loss of balance. There are multiple factors that can be associated, among which age, sex, family inherited and exposure to some toxins stand out.

Objective

To establish the association between smoking and the appearance of Parkinson's disease in people.

Materials and methods

A systematic review of documents produced between 2015 and 2020 in databases was carried out. Analytical observational studies that evaluated tobacco consumption (smoking) and the consequent development of Parkinson's disease were included. Data extraction was carried out by three researchers belonging to the project. The quality and risk of bias of the studies were assessed using the Newcastle-Ottawa scale.

Results

In total, 9 cohort studies that met the inclusion criteria were included, including a total of 12,533,445 people. The articles reported that tobacco consumption in people behaved as a protective factor, both in ex-smokers and in current smokers.

Conclusions

Despite the fact that smoking is a toxin that has been involved in the appearance of many pathologies, it has been found to behave as a protective factor for the development of Parkinson's disease.

导言帕金森病是一种神经退行性病变,成年后发病,表现为运动迟缓、静止性震颤、僵直、肌张力增高、运动阻力和姿势不稳且失去平衡。有多种因素可能与帕金森病有关,其中最突出的是年龄、性别、家族遗传和暴露于某些毒素。纳入了评估烟草消费(吸烟)与帕金森病发病之间关系的分析性观察研究。数据提取由项目的三名研究人员完成。采用纽卡斯尔-渥太华量表对研究的质量和偏倚风险进行了评估。结果共纳入了9项符合纳入标准的队列研究,共涉及12,533,445人。结论尽管吸烟是一种毒素,与许多病症的出现有关,但研究发现吸烟是帕金森病发病的一个保护因素。
{"title":"Enfermedad de Parkinson y tabaquismo: una revisión sistemática","authors":"Ledmar Jovanny Vargas Rodriguez ,&nbsp;Jamir Muñoz-Torres ,&nbsp;Duvier Fabián Meza ,&nbsp;José Mario Vásquez ,&nbsp;Oriana Saavedra Salinas","doi":"10.1016/j.neuarg.2024.05.001","DOIUrl":"10.1016/j.neuarg.2024.05.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Parkinson's disease is a neurodegenerative process of onset in adulthood, characterized by signs such as bradykinesia, resting tremor, rigidity, increased muscle tension, resistance to movement and postural instability with loss of balance. There are multiple factors that can be associated, among which age, sex, family inherited and exposure to some toxins stand out.</p></div><div><h3>Objective</h3><p>To establish the association between smoking and the appearance of Parkinson's disease in people.</p></div><div><h3>Materials and methods</h3><p>A systematic review of documents produced between 2015 and 2020 in databases was carried out. Analytical observational studies that evaluated tobacco consumption (smoking) and the consequent development of Parkinson's disease were included. Data extraction was carried out by three researchers belonging to the project. The quality and risk of bias of the studies were assessed using the Newcastle-Ottawa scale.</p></div><div><h3>Results</h3><p>In total, 9 cohort studies that met the inclusion criteria were included, including a total of 12,533,445 people. The articles reported that tobacco consumption in people behaved as a protective factor, both in ex-smokers and in current smokers.</p></div><div><h3>Conclusions</h3><p>Despite the fact that smoking is a toxin that has been involved in the appearance of many pathologies, it has been found to behave as a protective factor for the development of Parkinson's disease.</p></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"16 3","pages":"Pages 122-128"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141695692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ictus por embolia paradójica cerebral: reporte de caso de telangiectasia hemorrágica hereditaria 矛盾性脑栓塞中风:遗传性出血性毛细血管扩张症病例报告
Q4 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.neuarg.2024.08.003
Mario Suárez-Montalvo , Miguel A. Vences

Hereditary hemorrhagic telangiectasia or Rendu Osler Weber syndrome is a rare autosomal dominant genetic vascular disease. We present the case of a young adult who was admitted due to acute neurological deficit characterized by right motor deficit and aphasia due to acute ischemic stroke. The patient presented a history of previous epistaxis, presence of telangiectasias in the oral cavity, anemia and clubbing. A transcranial Doppler ultrasound revealed a right-left shunt and a pulmonary AVM was identified as the extracardiac cause of the shunt. The diagnosis of hereditary hemorrhagic telangiectasia is concluded, embolization is performed and subsequent left lower lobectomy correcting the AVM. The patient was discharged after the etiological study was completed, genetic counseling and outpatient rehabilitation therapy were provided. It is important to carry out a comprehensive evaluation in all young patients with stroke without classic cardiovascular risk factors, since carrying out appropriate diagnostic studies in a timely manner increases the probability of identifying the etiology, preventing the recurrence of new cerebrovascular events and improving the prognosis by providing adequate therapy.

遗传性出血性毛细血管扩张症或伦杜-奥斯勒-韦伯综合征是一种罕见的常染色体显性遗传血管病。本病例是一名因急性缺血性脑卒中导致右侧运动功能障碍和失语而入院的年轻成人。患者既往有鼻衄病史,口腔有毛细血管扩张、贫血和跛行。经颅多普勒超声检查发现患者存在右-左分流,肺动静脉畸形是导致分流的心外原因。诊断结论是遗传性出血性毛细血管扩张症,进行了栓塞治疗,随后进行了左下肺叶切除术,矫正了 AVM。在完成病因学研究、提供遗传咨询和门诊康复治疗后,患者痊愈出院。对所有无典型心血管危险因素的年轻脑卒中患者进行全面评估非常重要,因为及时进行适当的诊断研究可增加查明病因的可能性,防止新的脑血管事件复发,并通过提供适当的治疗改善预后。
{"title":"Ictus por embolia paradójica cerebral: reporte de caso de telangiectasia hemorrágica hereditaria","authors":"Mario Suárez-Montalvo ,&nbsp;Miguel A. Vences","doi":"10.1016/j.neuarg.2024.08.003","DOIUrl":"10.1016/j.neuarg.2024.08.003","url":null,"abstract":"<div><p>Hereditary hemorrhagic telangiectasia or Rendu Osler Weber syndrome is a rare autosomal dominant genetic vascular disease. We present the case of a young adult who was admitted due to acute neurological deficit characterized by right motor deficit and aphasia due to acute ischemic stroke. The patient presented a history of previous epistaxis, presence of telangiectasias in the oral cavity, anemia and clubbing. A transcranial Doppler ultrasound revealed a right-left shunt and a pulmonary AVM was identified as the extracardiac cause of the shunt. The diagnosis of hereditary hemorrhagic telangiectasia is concluded, embolization is performed and subsequent left lower lobectomy correcting the AVM. The patient was discharged after the etiological study was completed, genetic counseling and outpatient rehabilitation therapy were provided. It is important to carry out a comprehensive evaluation in all young patients with stroke without classic cardiovascular risk factors, since carrying out appropriate diagnostic studies in a timely manner increases the probability of identifying the etiology, preventing the recurrence of new cerebrovascular events and improving the prognosis by providing adequate therapy.</p></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"16 3","pages":"Pages 164-169"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accidente cerebrovascular isquémico y trombo flotante de la arteria carótida interna contralateral: ¿manejo médico o invasivo? 缺血性中风和对侧颈内动脉漂浮血栓:药物治疗还是侵入性治疗?
Q4 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.neuarg.2024.08.006
Alejandro Arango Martínez , Julián Mauricio Jiménez Álvarez , Luisa Fernanda Giraldo Ballesteros , Henry Quevedo Flórez , Juan Carlos Arrieta Bechara , Rafael Ignacio Herrera Ramos

Introduction

A free-floating carotid thrombus is a rare entity usually detected in the etiological study of an acute neurovascular syndrome.

Clinical case

We describe the case of a patient with ischemic cerebrovascular disease in the territory of the right middle cerebral artery with an incidental finding of a floating thrombus in the left internal carotid successfully treated with heparin and antiplatelet agents.

Conclusions

Carotid thrombosis is a rare entity. It represents a real therapeutic challenge as there are no unified treatment guidelines; however, the strategy based on anticoagulation is safe in most cases.

导言游离性颈动脉血栓是一种罕见病,通常是在急性神经血管综合征的病因研究中发现的。临床病例我们描述了一例右侧大脑中动脉缺血性脑血管病患者,偶然发现左侧颈内动脉有游离性血栓,经肝素和抗血小板药物治疗后成功治愈。结论颈动脉血栓形成是一种罕见病,由于没有统一的治疗指南,因此在治疗上是一个真正的挑战;不过,在大多数病例中,基于抗凝的策略是安全的。
{"title":"Accidente cerebrovascular isquémico y trombo flotante de la arteria carótida interna contralateral: ¿manejo médico o invasivo?","authors":"Alejandro Arango Martínez ,&nbsp;Julián Mauricio Jiménez Álvarez ,&nbsp;Luisa Fernanda Giraldo Ballesteros ,&nbsp;Henry Quevedo Flórez ,&nbsp;Juan Carlos Arrieta Bechara ,&nbsp;Rafael Ignacio Herrera Ramos","doi":"10.1016/j.neuarg.2024.08.006","DOIUrl":"10.1016/j.neuarg.2024.08.006","url":null,"abstract":"<div><h3>Introduction</h3><p>A free-floating carotid thrombus is a rare entity usually detected in the etiological study of an acute neurovascular syndrome.</p></div><div><h3>Clinical case</h3><p>We describe the case of a patient with ischemic cerebrovascular disease in the territory of the right middle cerebral artery with an incidental finding of a floating thrombus in the left internal carotid successfully treated with heparin and antiplatelet agents.</p></div><div><h3>Conclusions</h3><p>Carotid thrombosis is a rare entity. It represents a real therapeutic challenge as there are no unified treatment guidelines; however, the strategy based on anticoagulation is safe in most cases.</p></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"16 3","pages":"Pages 170-174"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalencia, caracterización y factores asociados en distonía craneocervical: un estudio de corte transversal 颅颈肌张力障碍的发病率、特征和相关因素:一项横断面研究。
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.neuarg.2024.02.004
Felipe Trujillo Ortiz , Tania Arrieta Hernández , María Paula Campos García , Juan David Vega Padilla , Larry Joel Caicedo Rojas , Cindy Paola Gómez Castaño , María Camila Silva Trujillo

Introduction

Craniocervical dystonia is a major cause of chronic pain, loss of quality of life and increased economic costs to health care systems.

Objectives

To determine the prevalence, characterize and define the factors associated with craniocervical dystonia in a center for movement disorders.

Methodology

Cross-sectional study that included patients with a diagnosis of craniocervical dystonia in the specialized clinic for movement disorders from January 1, 2011 to December 31, 2021 at the Institute of Neurology and Neurosurgery of Havana, Cuba.

Results

A total of 99 patients were included in the study and the prevalence was 15.23% in the movement disorders clinic. The median age was 66 years old (RIQ: 19) and 57.6% were female. The types of dystonia were distributed as follows: blepharospasm 48.48%, cervical dystonia 34.34%, multiple regions 9.09%, oromandibular dystonia 5.05% and spasmodic dysphonia 3.03%. The associated factors were: female sex OR: 2.521 [95% CI: 1.112-5.713] for blepharospasm, white race OR: 3.309 [95% CI: 1.146-9.558] and sensory trick OR: 9.960 [95% CI: 3.582-27.68] for cervical dystonia. Female sex OR: 0.075 [95% CI: 0.008-0.799], segmental onset form OR: 0.080 [95% CI: 0.008-0.799] and sensory trick OR: 0.081 [95% CI: 0.008-0.796] for oromandibular dystonia.

Conclusions

Craniocervical dystonia is frequent in clinics providing specialized care for patients with movement disorders, and the factors described were associated with specific types of dystonia.

导言颅颈肌张力障碍是导致慢性疼痛、生活质量下降和医疗保健系统经济成本增加的主要原因。 目的确定运动障碍中心颅颈肌张力障碍的患病率、特征和相关因素。方法横断面研究纳入古巴哈瓦那神经病学与神经外科研究所运动障碍专科门诊 2011 年 1 月 1 日至 2021 年 12 月 31 日期间确诊为颅颈肌张力障碍的患者。中位年龄为 66 岁(RIQ:19),57.6% 为女性。肌张力障碍的类型分布如下:眼睑痉挛 48.48%,颈肌张力障碍 34.34%,多区域肌张力障碍 9.09%,口颌肌张力障碍 5.05%,痉挛性发音障碍 3.03%。与之相关的因素有:女性,眼睑痉挛 OR:2.521 [95% CI:1.112-5.713];白人,眼睑痉挛 OR:3.309 [95% CI:1.112-5.713]:3.309[95%CI:1.146-9.558]和感觉障碍 OR:9.960[95%CI:3.582-27.68]。女性性别OR:0.075 [95% CI:0.008-0.799],节段性发病形式OR:0.080 [95% CI:0.008-0.799],感觉技巧OR:0.081 [95% CI:0.008-0.796],口颌肌张力障碍OR:0.081 [95% CI:0.008-0.796]。
{"title":"Prevalencia, caracterización y factores asociados en distonía craneocervical: un estudio de corte transversal","authors":"Felipe Trujillo Ortiz ,&nbsp;Tania Arrieta Hernández ,&nbsp;María Paula Campos García ,&nbsp;Juan David Vega Padilla ,&nbsp;Larry Joel Caicedo Rojas ,&nbsp;Cindy Paola Gómez Castaño ,&nbsp;María Camila Silva Trujillo","doi":"10.1016/j.neuarg.2024.02.004","DOIUrl":"10.1016/j.neuarg.2024.02.004","url":null,"abstract":"<div><h3>Introduction</h3><p>Craniocervical dystonia is a major cause of chronic pain, loss of quality of life and increased economic costs to health care systems.</p></div><div><h3>Objectives</h3><p>To determine the prevalence, characterize and define the factors associated with craniocervical dystonia in a center for movement disorders.</p></div><div><h3>Methodology</h3><p>Cross-sectional study that included patients with a diagnosis of craniocervical dystonia in the specialized clinic for movement disorders from January 1, 2011 to December 31, 2021 at the Institute of Neurology and Neurosurgery of Havana, Cuba.</p></div><div><h3>Results</h3><p>A total of 99 patients were included in the study and the prevalence was 15.23% in the movement disorders clinic. The median age was 66<!--> <!-->years old (RIQ: 19) and 57.6% were female. The types of dystonia were distributed as follows: blepharospasm 48.48%, cervical dystonia 34.34%, multiple regions 9.09%, oromandibular dystonia 5.05% and spasmodic dysphonia 3.03%. The associated factors were: female sex OR: 2.521 [95%<!--> <!-->CI: 1.112-5.713] for blepharospasm, white race OR: 3.309 [95%<!--> <!-->CI: 1.146-9.558] and sensory trick OR: 9.960 [95%<!--> <!-->CI: 3.582-27.68] for cervical dystonia. Female sex OR: 0.075 [95%<!--> <!-->CI: 0.008-0.799], segmental onset form OR: 0.080 [95%<!--> <!-->CI: 0.008-0.799] and sensory trick OR: 0.081 [95%<!--> <!-->CI: 0.008-0.796] for oromandibular dystonia.</p></div><div><h3>Conclusions</h3><p>Craniocervical dystonia is frequent in clinics providing specialized care for patients with movement disorders, and the factors described were associated with specific types of dystonia.</p></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"16 2","pages":"Pages 51-58"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140268500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ptosis y oftalmoparesia bilateral como presentaciones atípicas de infarto de arteria de Percheron: reporte de caso 双侧上睑下垂和眼球偏瘫是佩切龙动脉梗塞的非典型表现:病例报告。
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.neuarg.2024.03.002
Juan Pereyra , Miguel A. Vences

The Percheron artery is a rare arterial variant that irrigates the thalamic region bilaterally. Infarction due to obstruction of the Percheron artery has been reported at a frequency between 0.1 to 2% and classically causes an alteration in the level of consciousness, neurocognitive disorder and vertical gaze palsy. We present a 70-year-old female patient with altered level of consciousness, involvement of vertical gaze palsy, ophthalmoparesis and bilateral ptosis. The patient progressed with partial improvement of symptoms: she persisted severe bilateral ptosis and paresis of vertical gaze with slight improvement of the alteration of horizontal gaze and bilateral internuclear ophthalmoplegia. In conclusion, we report the atypical case of an infarction of the artery of Percheron and describe the anatomical substrate for presenting these clinical signs. It is important to suspect a possible case in every patient with symptoms of compromised level of consciousness and alteration in ocular mobility since this will allow us to make a timely diagnosis and treatment.

珀切龙动脉是一种罕见的动脉变异,双侧灌注丘脑区域。据报道,因佩尔琼动脉阻塞而导致的脑梗塞发生率在 0.1% 到 2% 之间,通常会导致意识水平改变、神经认知障碍和垂直凝视麻痹。我们接诊了一名 70 岁的女性患者,她意识水平改变,伴有垂直凝视麻痹、眼肌麻痹和双侧上睑下垂。患者的症状得到部分改善:她持续存在严重的双侧上睑下垂和垂直凝视麻痹,但水平凝视改变和双侧核内眼瘫略有改善。总之,我们报告了一例非典型的佩切龙动脉梗塞病例,并描述了出现这些临床症状的解剖基础。重要的是,我们要怀疑每一位出现意识障碍和眼球活动度改变症状的患者都有可能是这种病例,因为这将有助于我们及时诊断和治疗。
{"title":"Ptosis y oftalmoparesia bilateral como presentaciones atípicas de infarto de arteria de Percheron: reporte de caso","authors":"Juan Pereyra ,&nbsp;Miguel A. Vences","doi":"10.1016/j.neuarg.2024.03.002","DOIUrl":"10.1016/j.neuarg.2024.03.002","url":null,"abstract":"<div><p>The Percheron artery is a rare arterial variant that irrigates the thalamic region bilaterally. Infarction due to obstruction of the Percheron artery has been reported at a frequency between 0.1 to 2% and classically causes an alteration in the level of consciousness, neurocognitive disorder and vertical gaze palsy. We present a 70-year-old female patient with altered level of consciousness, involvement of vertical gaze palsy, ophthalmoparesis and bilateral ptosis. The patient progressed with partial improvement of symptoms: she persisted severe bilateral ptosis and paresis of vertical gaze with slight improvement of the alteration of horizontal gaze and bilateral internuclear ophthalmoplegia. In conclusion, we report the atypical case of an infarction of the artery of Percheron and describe the anatomical substrate for presenting these clinical signs. It is important to suspect a possible case in every patient with symptoms of compromised level of consciousness and alteration in ocular mobility since this will allow us to make a timely diagnosis and treatment.</p></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"16 2","pages":"Pages 100-104"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140773142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuropatía sensitivo-motora hereditaria tipo Russe en etnia gitana 吉普赛人的遗传性鲁斯型感觉运动神经病
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.neuarg.2024.03.004
Ana Castrillo, Amelia Mendoza, Lorena Caballero, Débora Cerdán, Fernanda Rodríguez, Patricia Gil, Julián Berrío, Jacinto Duarte

Charcot-Marie-Tooth (CMT) disease is the most common hereditary neuropathy, having a prevalence of 28,2 cases per 100.000 inhabitants. It is one of the genetically most complex neurodegenerative syndromes in which 31 cloned pathogenic genes have been described. Demyelinating forms with autosomal recessive transmission represent 4% of the European population affected by CMT. In countries with high consanguinity risk, the percentage may be higher. In gypsy ethnic groups it must be considered that three founding mutations represent three variants: CMT4D Lom type (NDRG1 mutation), CMT4G Russe type (HK1 mutation) and CMT4C (SH3TC2 mutation) all of them described in Spain. In this article, three cases of demyelinating CMT AR heredity and HK1 mutations will be discussed for the same gypsy families.

Charcot-Marie-Tooth 病(CMT)是最常见的遗传性神经病,发病率为每 10 万居民 28.2 例。它是遗传学上最复杂的神经退行性综合征之一,目前已发现 31 个克隆致病基因。常染色体隐性遗传的脱髓鞘型占欧洲 CMT 患者的 4%。在近亲结婚风险较高的国家,这一比例可能更高。在吉普赛族群中,必须考虑到三种基因突变代表了三种变体:CMT4D Lom 型(NDRG1 突变)、CMT4G Russe 型(HK1 突变)和 CMT4C 型(SH3TC2 突变)均在西班牙出现过。本文将讨论三个脱髓鞘型 CMT AR 遗传和 HK1 基因突变的吉普赛家庭。
{"title":"Neuropatía sensitivo-motora hereditaria tipo Russe en etnia gitana","authors":"Ana Castrillo,&nbsp;Amelia Mendoza,&nbsp;Lorena Caballero,&nbsp;Débora Cerdán,&nbsp;Fernanda Rodríguez,&nbsp;Patricia Gil,&nbsp;Julián Berrío,&nbsp;Jacinto Duarte","doi":"10.1016/j.neuarg.2024.03.004","DOIUrl":"https://doi.org/10.1016/j.neuarg.2024.03.004","url":null,"abstract":"<div><p>Charcot-Marie-Tooth (CMT) disease is the most common hereditary neuropathy, having a prevalence of 28,2 cases per 100.000 inhabitants. It is one of the genetically most complex neurodegenerative syndromes in which 31 cloned pathogenic genes have been described. Demyelinating forms with autosomal recessive transmission represent 4% of the European population affected by CMT. In countries with high consanguinity risk, the percentage may be higher. In gypsy ethnic groups it must be considered that three founding mutations represent three variants: CMT4D Lom type (NDRG1 mutation), CMT4G Russe type (HK1 mutation) and CMT4C (SH3TC2 mutation) all of them described in Spain. In this article, three cases of demyelinating CMT AR heredity and HK1 mutations will be discussed for the same gypsy families.</p></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"16 2","pages":"Pages 105-108"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141434251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurologia Argentina
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1